. GlueckCJ, LangJ, HamerT, TracyT. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemic women. J Lab Clin Med1994; 123: 59–64.
2.
. NaranjoCA, BustoU, SellersEM, SandorP, RuizI, RobertsEA, A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
3.
. GoldenbergNM, WangP, GlueckCJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta2003; 332: 11–9.
4.
. DavidoffF, TishlerS, RosoffC. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med1973; 289: 552–5.
5.
. PeregoE, ScainiA, RomanoF, FranciosiC, UggeriF. Estrogen-induced severe acute pancreatitis in a male. J Pancreas2004; 5: 353–6.
6.
. BlakeWE, PitcherME. Estrogen-related pancreatitis in the setting of normal plasma lipids: case report. Menopause2003; 10: 99–101.
